AgelessRx Co-Founder and Chief Medical Officer, Dr. Sajad Zalzala, recently gave an update on the growth of AgelessRx and an insight into its big plans at the Healthcare Future conference.
In his presentation, Dr. Zalzala covered lots of topics, ranging from how COVID-19 has accelerated the uptake of telemedicine to the drivers behind why we age and how AgelessRx plans to help slow them down.
He also delved into topics like Steve Horvath’s methylation clocks and AgelessRx’s upcoming clinical trial on Rapamycin (PEARL), as well as revealing some of the new treatments soon coming to AgelessRx’s offerings.
Watch Dr. Z’s presentation in full and hear the exciting news for yourself by clicking the video below:
About Dr. Zalzala
Dr. Zalzala combines the unique qualities of an experienced doctor passionate about disease prevention and longevity with the strategic vision and skills of a serial entrepreneur. Dr. Zalzala has been passionate about slowing and reversing age-related diseases for 20 years. In fact, he is one of the rare MD’s personally licensed in all 50 states, as well as Washington D.C. and Ontario. He has extensive experience working with startup companies in the telemedicine/telehealth field and has been an advisor to multiple successful healthcare startups, including Pill Club, Jack Health, forHims, and now AgelessRx.